89 related articles for article (PubMed ID: 9375778)
1. Central nervous system relapse in acute promyelocytic leukaemia treated with ATRA.
Currie J; Chee YL; Culligan DJ
Br J Haematol; 1997 Nov; 99(2):469. PubMed ID: 9375778
[No Abstract] [Full Text] [Related]
2. Central nervous system involvement at second relapse in acute promyelocytic leukemia treated with ATRA and chemotherapy.
Kumar B; Sharma V; Chopra A; Mahapatra M; Kumar R; Mathur S; Sazawal S; Kumar S; Saxena R
Leuk Res; 2010 Oct; 34(10):e264-5. PubMed ID: 20537387
[No Abstract] [Full Text] [Related]
3. Pituitary relapse of acute promyelocytic leukemia after ATRA.
Lugassy G; Halperin Y
Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
[No Abstract] [Full Text] [Related]
4. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
Castagnola C; Elena C; Merli M
Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid.
Evans G; Grimwade D; Prentice HG; Simpson N
Br J Haematol; 1997 Aug; 98(2):437-9. PubMed ID: 9266945
[TBL] [Abstract][Full Text] [Related]
6. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Yang J; Han Z; Pei M; Xiao N
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system relapse in acute promyelocytic leukemia.
Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
[No Abstract] [Full Text] [Related]
8. [Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].
Maeda A; Kobayashi Y; Saito T; Togitani K; Kawahigashi N; Tanosaki R; Takaue Y; Takenaka T; Iwata N; Tobinai K
Rinsho Ketsueki; 1999 Oct; 40(10):1081-6. PubMed ID: 10565225
[TBL] [Abstract][Full Text] [Related]
9. [All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia].
Taguchi A; Takahashi T; Harima Y; Takemoto Y; Ando T; Nomiyama J; Matsubara A; Yujiri T; Tanizawa Y
Rinsho Ketsueki; 2005 Mar; 46(3):202-5. PubMed ID: 16447715
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system acute promyelocytic leukaemia: a report of three cases.
Marra R; Stori S; Pagano L; Fioritoni G; Rabitti C; Sica S; Leone G; Torlontano G; Bizzi B
Haematologia (Budap); 1989; 22(3):195-9. PubMed ID: 2583600
[TBL] [Abstract][Full Text] [Related]
11. [All-trans retinoic acid for thromboembolic events in patients with M3 leukemia: a case report].
Yin F; Zheng WY; Meng FY; Jiang ZJ; Liu XL; Feng R; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):187-8. PubMed ID: 12581981
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.
Jácomo RH; Melo RA; Souto FR; de Mattos ER; de Oliveira CT; Fagundes EM; Bittencourt HN; Bittencourt RI; Bortolheiro TC; Paton EJ; Bendlin R; Ismael S; Chauffaille Mde L; Silva D; Pagnano KB; Ribeiro R; Rego EM
Haematologica; 2007 Oct; 92(10):1431-2. PubMed ID: 18024380
[TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
14. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
Lo Coco F
Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
[No Abstract] [Full Text] [Related]
15. [Isolated relapse in the central nervous system during cytologic and hematologic remission in a patient with acute promyelocytic leukemia].
Vivanco-Hidalgo RM; Gimeno E; Gálvez A; Rodríguez-Campello A
Neurologia; 2010 Apr; 25(3):200-1. PubMed ID: 20492869
[No Abstract] [Full Text] [Related]
16. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
[TBL] [Abstract][Full Text] [Related]
17. Genital ulcers after treatment with all-trans-retinoic acid in a child with acute promyelocytic leukemia.
Unal S; Gümrük F; Cetin M; Hiçsönmez G
Pediatr Hematol Oncol; 2005; 22(5):357-9. PubMed ID: 16020125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
19. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience.
Zhang L; Zhao H; Zhu X; Chen Y; Zou Y; Chen X
Pediatr Blood Cancer; 2008 Aug; 51(2):210-5. PubMed ID: 18428427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
